Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Novo Nordisk A/S Sponsored ADR (NVO)
Market Closed
16 Oct, 08:00 PM
NYSE
All
(7)
DE
(4)
MX
(1)
GB
(1)
US
(1)
NYSE
Primary
LSE
XFRA
XDUS
XMUN
XMEX
XSTU
$
38.
83
-0.39
-0.9944%
After Hours
$
38.
83
0
0%
169.01B
Market Cap
48.26
P/E Ratio
0.32%
Div Yield
9.46M
Volume
0
Eps
$
39.22
Previous Close
Investors:
TJD
DI
+383
Analysts:
TB
Watching
Watch
Add Transaction
Day Range
38.67
39.4
Year Range
35.12
64.16
Want to track
NVO
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Novo Nordisk A/S Sponsored ADR (NVO) Statistics
Valuation metrics
Market Cap
169.01B
Enterprise value
1.23T
Trailing P/E (ttm)
9.73
Forward P/E
11.21
PEG ratio
1.94
Price/Sales (ttm)
3.44
Price/Book (mrq)
5.11
Enterprise Value/Revenue
3.73
Enterprise Value/EBITDA
6.93
Overview
Shares outstanding
4.44B
Float
3.19B
Shares short
19.93M
% Held by insiders
0%
% Held by institutions
0.09%
Average volume (10 days)
13.99M
Average volume (90 days)
12.1M
Price summary
52-Week low
35.12
52-Week high
64.16
Beta
0.27
50-Day moving average
41.2
200-Day moving average
43.25
Dividends and splits
Forward annual dividend rate
2.55
Forward annual dividend yield
0.0619%
Trailing annual dividend rate
11.7
Trailing annual dividend yield
0.0458%
5-Year annual dividend yield
1.72%
Payout ratio
0.45
Dividend Date
25 Aug 2026
Ex-Dividend Date
17 Aug 2026
Last split factor
2:1
Last split Date
20 Sep 2023
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.35%
Operating margin
0.43%
Operational effectiveness
Return on assets
0.2%
Return on equity
0.59%
Income Statement
Revenue (ttm)
48.34B
Revenue per share (ttm)
74.4
Quarterly revenue growth (yoy)
-0.08%
Gross profit (ttm)
39.84B
EBITDA
158.38B
Net income to common (ttm)
16.02B
Diluted EPS (ttm)
26.3
Quarterly earnings growth (yoy)
-0.05%
Balance Sheet
Total cash (mrq)
4.22B
Total cash per share (mrq)
10.16
Total debt (mrq)
20.48B
Total Debt/Equity (mrq)
0.63
Current ratio (mrq)
0.87%
Book value per share (mrq)
49.97
Cash Flow
Cash flow statement
18.63B
Levered free cash flow (LFCF)
58.95M